JACQUELINE MILLARD: Open Payments
NPI 1528767167 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 16 payments from 10 companies in 2025. Trend: 2023 $199 · 2024 $336 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| CVRx, Inc. | 1 | $27 |
| BridgeBio Pharma, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: ONPATTRO, LEQVIO, CAMZYOS, Barostim Neo System, Attruby, VERQUVO, SHINGRIX, AREXVY.
Industry payments across NY — which companies pay providers there.
